Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions
Script Name –CIPLA
Buy Price – 928.00-928.50
Profit Target-948
Stop Loss-917
Call Duration-Intraday
Disclaimer : Trading in the stock market, currency, or commodity markets is risky and has the potential to lose money. –Atal Trade Effort calls you after analyzing all aspects of all stocks. Investing is a personal matter. However, only one. The risk of loss in trading and investment in Securities markets including Equities, Derivatives, commodities, and Currency can be substantial. All products that carry a substantial risk of loss up to your invested capital. It May not be suitable for everyone. You should therefore carefully consider whether such trading is suitable for you in light of your financial condition. You invest a portion of your total money that will not be affected by the loss. Never put all your money into trading and never borrow money for the business.
Leave a Reply